252 related articles for article (PubMed ID: 28748388)
1. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
[TBL] [Abstract][Full Text] [Related]
2. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
[TBL] [Abstract][Full Text] [Related]
3. A novel frameshift deletion in PLS3 causing severe primary osteoporosis.
Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A
J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797
[TBL] [Abstract][Full Text] [Related]
4. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women.
Shao C; Wang YW; He JW; Fu WZ; Wang C; Zhang ZL
Acta Pharmacol Sin; 2019 Sep; 40(9):1212-1218. PubMed ID: 30837644
[TBL] [Abstract][Full Text] [Related]
7. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
[TBL] [Abstract][Full Text] [Related]
8. Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties.
Balasubramanian M; Fratzl-Zelman N; O'Sullivan R; Bull M; Fa Peel N; Pollitt RC; Jones R; Milne E; Smith K; Roschger P; Klaushofer K; Bishop NJ
Am J Med Genet A; 2018 Jul; 176(7):1578-1586. PubMed ID: 29736964
[TBL] [Abstract][Full Text] [Related]
9. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
[TBL] [Abstract][Full Text] [Related]
10. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Genetic Features in Five New Families.
Costa A; Martins A; Machado C; Lundberg E; Nilsson O; Wang F; Costantini A; Tournis S; Höppner J; Grasemann C; Mäkitie O
Calcif Tissue Int; 2024 Feb; 114(2):157-170. PubMed ID: 38043102
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
[TBL] [Abstract][Full Text] [Related]
12. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
[TBL] [Abstract][Full Text] [Related]
13. PLS3 mutations in X-linked osteoporosis with fractures.
van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
[TBL] [Abstract][Full Text] [Related]
14. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
[TBL] [Abstract][Full Text] [Related]
15. Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.
Cohen A; Hostyk J; Baugh EH; Buchovecky CM; Aggarwal VS; Recker RR; Lappe JM; Dempster DW; Zhou H; Kamanda-Kosseh M; Bucovsky M; Stubby J; Goldstein DB; Shane E
Bone; 2022 Jan; 154():116253. PubMed ID: 34743040
[TBL] [Abstract][Full Text] [Related]
16.
Mäkitie RE; Niinimäki T; Suo-Palosaari M; Kämpe A; Costantini A; Toiviainen-Salo S; Niinimäki J; Mäkitie O
Front Endocrinol (Lausanne); 2020; 11():393. PubMed ID: 32655496
[No Abstract] [Full Text] [Related]
17. A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta.
Hu J; Li LJ; Zheng WB; Zhao DC; Wang O; Jiang Y; Xing XP; Li M; Xia W
Mol Genet Genomic Med; 2020 Dec; 8(12):e1525. PubMed ID: 33166085
[TBL] [Abstract][Full Text] [Related]
18. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
[TBL] [Abstract][Full Text] [Related]
19. Plastin 3 influences bone homeostasis through regulation of osteoclast activity.
Neugebauer J; Heilig J; Hosseinibarkooie S; Ross BC; Mendoza-Ferreira N; Nolte F; Peters M; Hölker I; Hupperich K; Tschanz T; Grysko V; Zaucke F; Niehoff A; Wirth B
Hum Mol Genet; 2018 Dec; 27(24):4249-4262. PubMed ID: 30204862
[TBL] [Abstract][Full Text] [Related]
20. Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation.
van de Laarschot DM; Zillikens MC
Bone; 2016 Oct; 91():148-51. PubMed ID: 27477003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
